Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.

OBJECTIVE The purpose of our study was to compare the visibility of prostate cancer on trace diffusion-weighted (DW) images and the apparent diffusion coefficient (ADC) map. MATERIALS AND METHODS In this retrospective study, 45 patients with prostate cancer underwent preoperative MRI, including DW imaging (DWI) (b values 0, 500, and 1,000 s/mm(2)). A single observer reviewed the images in conjunction with tumor maps constructed from prostatectomy. For 132 peripheral zone (PZ) tumor foci, the visibility and contrast relative to benign PZ were recorded for T2-weighted imaging, trace DWI b500 images, trace DWI b1,000 images, and ADC maps. Trace DWI b1,000 images and ADC maps were compared in terms of Gleason score, size, normalized T2 signal intensity, ADC, and normalized ADC of visible tumors. RESULTS For each image set, the percentage of visible tumor foci and contrast relative to benign PZ were as follows: T2-weighted imaging, 80.3% and 0.411; trace DWI b500, 26.5% and 0.131; trace DWI b1,000, 46.2% and 0.119; and ADC maps, 62.1% and 0.309. Forty-seven tumor foci were visible on both trace DWI b1,000 images and ADC maps, 14 only on trace DWI b1,000 images, 35 only on ADC maps, and 36 on neither image set. There was no significant difference in Gleason score, size, normalized T2 signal intensity, ADC, or normalized ADC between tumors visible only on trace DWI b1,000 images and those visible only on ADC maps. CONCLUSION Given a greater proportion of tumors visible on the ADC map than trace DWI and greater contrast relative to benign PZ on the ADC map, we suggest that, when performing DWI of the prostate, careful attention be given to the ADC map for tumor identification.

[1]  S. Atlas,et al.  Diffusion-weighted MR of acute cerebral infarction: comparison of data processing methods. , 1998, AJNR. American journal of neuroradiology.

[2]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[3]  S. Heiland,et al.  Noise correction for the exact determination of apparent diffusion coefficients at low SNR , 2001, Magnetic resonance in medicine.

[4]  Peter Gibbs,et al.  Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.

[5]  V. Pansadoro,et al.  Prostate cancer: evaluation with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 2004, La Radiologia medica.

[6]  Peter L Choyke,et al.  Imaging prostate cancer: a multidisciplinary perspective. , 2007, Radiology.

[7]  Anders Kristoffersen,et al.  Optimal estimation of the diffusion coefficient from non-averaged and averaged noisy magnitude data. , 2007, Journal of magnetic resonance.

[8]  Takeo Ishigaki,et al.  Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.

[9]  S. Kyriazi,et al.  Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection , 2007, Acta radiologica.

[10]  Masoom A Haider,et al.  Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.

[11]  Namkug Kim,et al.  Functional MR imaging of prostate cancer. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[12]  Byung Kwan Park,et al.  Value of Diffusion-Weighted Imaging for the Prediction of Prostate Cancer Location at 3T Using a Phased-Array Coil: Preliminary Results , 2007, Investigative radiology.

[13]  D. Collins,et al.  Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.

[14]  Masao Fukunaga,et al.  Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. , 2008, Radiology.

[15]  D. Dearnaley,et al.  Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimens. , 2008, The British journal of radiology.

[16]  K. Sugimura,et al.  High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. , 2008, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[17]  Deanna L Langer,et al.  Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.

[18]  N. Narula,et al.  Characterization of genitourinary lesions with diffusion-weighted imaging. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[19]  S. Dymarkowski,et al.  Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma , 2009, European Radiology.

[20]  Baris Turkbey,et al.  Imaging localized prostate cancer: current approaches and new developments. , 2009, AJR. American journal of roentgenology.

[21]  H. Honda,et al.  Prostate cancer detection: the value of performing an MRI before a biopsy , 2009, Acta radiologica.

[22]  H. Hricak,et al.  Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer. , 2009, Radiology.

[23]  Junqian Xu,et al.  Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans , 2009, Magnetic resonance in medicine.

[24]  K. Chida,et al.  Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. , 2009, Radiology.

[25]  Amita Shukla-Dave,et al.  Functional magnetic resonance imaging in prostate cancer. , 2009, European urology.

[26]  Peter Choyke,et al.  Challenges in clinical prostate cancer: role of imaging. , 2009, AJR. American journal of roentgenology.

[27]  Kyung Ah Kim,et al.  Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study. , 2009, Radiology.

[28]  A. Thompson,et al.  MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters. , 2009, AJR. American journal of roentgenology.

[29]  J. Machan,et al.  Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. , 2010, AJR. American journal of roentgenology.

[30]  C. Kim,et al.  High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. , 2010, AJR. American journal of roentgenology.

[31]  Kazuro Sugimura,et al.  Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.

[32]  J. Babb,et al.  Prostate cancer vs. post‐biopsy hemorrhage: Diagnosis with T2‐ and diffusion‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.

[33]  J. Babb,et al.  Prostate cancer: Utility of fusion of T2‐weighted and high b‐value diffusion‐weighted images for peripheral zone tumor detection and localization , 2011, Journal of magnetic resonance imaging : JMRI.

[34]  T. Metens,et al.  What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? , 2012, European Radiology.

[35]  T. Nakazono,et al.  Diffusion-weighted MR imaging in gynecologic cancers , 2011, Journal of gynecologic oncology.

[36]  P Puech,et al.  Detecting prostate cancer with MRI - why and how. , 2012, Diagnostic and interventional imaging.

[37]  E. Sala,et al.  The emerging role of diffusion-weighted MRI in prostate cancer management , 2012, Nature Reviews Urology.

[38]  P. Puech,et al.  Pourquoi et comment détecter le cancer de la prostate en IRM , 2012 .

[39]  B. K. Park,et al.  Diffusion-Weighted Magnetic Resonance Imaging for the Evaluation of Prostate Cancer: Optimal B Value at 3T , 2012, Korean journal of radiology.